Literature DB >> 7815525

Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes.

W M Switzer1, D Pieniazek, P Swanson, H H Samdal, V Soriano, R F Khabbaz, J E Kaplan, R B Lal, W Heneine.   

Abstract

The current env-based subtyping of human T-cell lymphotropic virus type II (HTLV-II) identifies only two heterogenetic groups, HTLV-IIa and HTLV-IIb. To better understand the genetic diversity and phylogeny of HTLV-II, we examined the most divergent genomic region of HTLV-II, the long terminal repeat, by using restriction fragment length polymorphism (RFLP) and sequence analysis. Long terminal repeat sequences were amplified from peripheral blood mononuclear cells by PCR and digested with seven restriction endonucleases that differentiated HTLV-II into five HTLV-IIa (IIa0 to IIa4) and six HTLV-IIb (IIb0 to IIb5) restriction types, with HTLV-IIa0 and HTLV-IIb0 being prototypes for the MoT and NRA isolates, respectively. We examined 169 HTLV-II-infected samples, including 123 from blood donors and intravenous drug users (IDU) from the Americas, 16 from IDU from Europe, and 30 from Amerindians. Of the 169 samples, 109 (64.5%) were categorized as HTLV-IIa and 60 (35.5%) were categorized as HTLV-IIb. The predominant restriction types seen among the U.S. blood donors and U.S. IDU were IIa0 (68.7%) and IIb4 (10.4%). Four Spanish and seven Italian samples were IIb4, while five Norwegian samples were IIa2. Twelve Guaymi and all ten Seminole samples were single restriction types (IIb1 and IIb5, respectively), whereas the two Navajo and six Pueblo samples had a mixture of restriction types IIa0, IIa4, and IIb5. Of the HTLV-IIb restriction types observed in the U.S. non-Indians, 42.8% appear to have originated from the North Amerindian (IIb5), while 57.2% were similar to the European IIb4 restriction type. Sequences of 15 selected HTLV-II samples were determined and phylogenetically compared with 7 previously published HTLV-II LTR sequences. The derived topologies revealed three HTLV-IIa phylogroups (A-I to A-III) and four HTLV-IIb phylogroups (B-I to B-IV). Furthermore, the HTLV-IIa phylogroups appear to have evolved from the HTLV-IIb phylogroups. In the HTLV-IIa cluster, a Navajo (A-I) and a Brazilian (A-II) sequence formed separate phylogroups, while the remaining IIa sequences formed a single phylogroup (A-III). The four HTLV-IIb phylogroups were represented predominantly by a New York IDU (B-I), European IDU (B-II), North Amerindian and NRA (B-III), and Central Guaymi Indian (B-IV) sequence(s). Comparison of the phylogenetic data with the RFLP results revealed that results of the two methods correlated completely, demonstrating the ability of the RFLP method to predict the phylogroup of HTLV-II-infected samples accurately and quickly. GENBANK/U10258

Entities:  

Mesh:

Year:  1995        PMID: 7815525      PMCID: PMC188622     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Native American mitochondrial DNA analysis indicates that the Amerind and the Nadene populations were founded by two independent migrations.

Authors:  A Torroni; T G Schurr; C C Yang; E J Szathmary; R C Williams; M S Schanfield; G A Troup; W C Knowler; D N Lawrence; K M Weiss
Journal:  Genetics       Date:  1992-01       Impact factor: 4.562

Review 2.  The epidemiology of the human T-cell lymphotrophic virus type I and type II: etiologic role in human disease.

Authors:  A Manns; W A Blattner
Journal:  Transfusion       Date:  1991-01       Impact factor: 3.157

3.  Complete nucleotide sequence of an infectious clone of human T-cell leukemia virus type II: an open reading frame for the protease gene.

Authors:  K Shimotohno; Y Takahashi; N Shimizu; T Gojobori; D W Golde; I S Chen; M Miwa; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

4.  HTLV-1 and polymyositis in Jamaica.

Authors:  O S Morgan; P Rodgers-Johnson; C Mora; G Char
Journal:  Lancet       Date:  1989-11-18       Impact factor: 79.321

5.  HTLV-II infection in Florida Indians.

Authors:  P H Levine; S Jacobson; R Elliott; A Cavallero; G Colclough; C Dorry; C Stephenson; R M Knigge; J Drummond; M Nishimura
Journal:  AIDS Res Hum Retroviruses       Date:  1993-02       Impact factor: 2.205

6.  Molecular characterization of two isolates of human T cell leukaemia virus type II from Italian drug abusers and comparison of genome structure with other isolates.

Authors:  D Zella; A Cavicchini; M Salemi; C Casoli; F Lori; G Achilli; E Cattaneo; V Landini; U Bertazzoni
Journal:  J Gen Virol       Date:  1993-03       Impact factor: 3.891

7.  Association of '(tropical) ataxic neuropathy' with HTLV-II.

Authors:  W A Sheremata; W J Harrington; P A Bradshaw; S K Foung; S P Raffanti; J R Berger; S Snodgrass; L Resnick; B J Poiesz
Journal:  Virus Res       Date:  1993-07       Impact factor: 3.303

8.  HTLV-II seroprevalence in pygmies across Africa since 1970.

Authors:  P Goubau; H F Liu; G G De Lange; A M Vandamme; J Desmyter
Journal:  AIDS Res Hum Retroviruses       Date:  1993-08       Impact factor: 2.205

9.  Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease.

Authors:  M Yoshida; M Seiki; K Yamaguchi; K Takatsuki
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

10.  Genetic heterogeneity in human T-cell leukemia/lymphoma virus type II.

Authors:  D K Dube; M P Sherman; N K Saksena; V Bryz-Gornia; J Mendelson; J Love; C B Arnold; T Spicer; S Dube; J B Glaser
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

View more
  28 in total

1.  Evidence of infection with simian type D retrovirus in persons occupationally exposed to nonhuman primates.

Authors:  N W Lerche; W M Switzer; J L Yee; V Shanmugam; A N Rosenthal; L E Chapman; T M Folks; W Heneine
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Molecular evidence for infection by HTLV-2 among individuals with negative serological screening tests for HTLV antibodies.

Authors:  R Ishak; A C R Vallinoto; V N Azevedo; A C P Vicente; W W Hall; M O G Ishak
Journal:  Epidemiol Infect       Date:  2006-09-07       Impact factor: 2.451

3.  African origin of human T-lymphotropic virus type 2 (HTLV-2) supported by a potential new HTLV-2d subtype in Congolese Bambuti Efe Pygmies.

Authors:  A M Vandamme; M Salemi; M Van Brussel; H F Liu; K Van Laethem; M Van Ranst; L Michels; J Desmyter; P Goubau
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 4.  The origin and evolution of human T-cell lymphotropic virus types I and II.

Authors:  Y Suzuki; T Gojobori
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

5.  Emergence of a novel and highly divergent HTLV-3 in a primate hunter in Cameroon.

Authors:  HaoQiang Zheng; Nathan D Wolfe; David M Sintasath; Ubald Tamoufe; Matthew Lebreton; Cyrille F Djoko; Joseph Le Doux Diffo; Brian L Pike; Walid Heneine; William M Switzer
Journal:  Virology       Date:  2010-03-30       Impact factor: 3.616

6.  Identification and molecular characterization of new simian T cell lymphotropic viruses in nonhuman primates bushmeat from the Democratic Republic of Congo.

Authors:  Steve Ahuka-Mundeke; Placide Mbala-Kingebeni; Florian Liegeois; Ahidjo Ayouba; Octavie Lunguya-Metila; Didace Demba; Guy Bilulu; Valentin Mbenzo-Abokome; Bila-Isia Inogwabini; Jean-Jacques Muyembe-Tamfum; Eric Delaporte; Martine Peeters
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-14       Impact factor: 2.205

7.  Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2.

Authors:  N Eiraku; P Novoa; M da Costa Ferreira; C Monken; R Ishak; O da Costa Ferreira; S W Zhu; R Lorenco; M Ishak; V Azvedo; J Guerreiro; M P de Oliveira; P Loureiro; N Hammerschlak; S Ijichi; W M Hall
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

8.  Molecular subtyping of human T-cell lymphotropic virus type 2 by single-strand conformation polymorphism analysis. Retrovirus Epidemiology Donor Study Group.

Authors:  W Heneine; W M Switzer; M Busch; R F Khabbaz; J E Kaplan
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

9.  Enhanced specificity of truncated transmembrane protein for serologic confirmation of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 infections by western blot (immunoblot) assay containing recombinant envelope glycoproteins.

Authors:  M Varma; D L Rudolph; M Knuchel; W M Switzer; K G Hadlock; M Velligan; L Chan; S K Foung; R B Lal
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

10.  Genetic characterization of the complete genome of a highly divergent simian T-lymphotropic virus (STLV) type 3 from a wild Cercopithecus mona monkey.

Authors:  David M Sintasath; Nathan D Wolfe; Hao Qiang Zheng; Matthew LeBreton; Martine Peeters; Ubald Tamoufe; Cyrille F Djoko; Joseph L D Diffo; Eitel Mpoudi-Ngole; Walid Heneine; William M Switzer
Journal:  Retrovirology       Date:  2009-10-27       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.